Third Wave Shareholders Tender 92 Percent of Shares to Hologic

Jul 17, 2008

NEW YORK (GenomeWeb News) – Hologic said today that Third Wave Technologies' shareholders have tendered approximately 45,225,950 shares, or around 92.1 percent of the company’s outstanding stock, as of the close of its initial offering period to acquire Third Wave, which expired last night.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Faster Profiles

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Conflict Search

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

This Week in Science

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Main menu